James E. Crowe

Duke-NUS Medical School — Singapore

Medicine · Health Sciences

98h-index37.7kcitations1.3kworks5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(185), Viral gastroenteritis research and epidemiology(123), Influenza Virus Research Studies(119), Viral Infections and Vectors(118), Monoclonal and Polyclonal Antibodies Research(115)

Publications834 total

Strengthening supply chains for pathogen genomic surveillance in Asia
BMJ Global Health·2026Open Access
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Cell Reports Medicine·2026Open Access
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice.
UNC Libraries·2025Open Access
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Journal of Clinical Investigation·2025Open Access
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity
Journal of Virology·2025Open Access
Human coronavirus HKU1 neutralization by glycan receptor mimicry
2025Open Access
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice
Journal of Virology·2025Open Access
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation
The Lancet Global Health·2025· 5 citedOpen Access
Discovery and characterization of potently neutralizing human monoclonal antibodies against Mayaro virus 4371
The Journal of Immunology·2025
Isolation of a panel neutralizing human antibodies against measles virus 4369
The Journal of Immunology·2025Open Access
Multiple LDLR family members act as entry receptors for yellow fever virus
Nature·2025· 3 cited
Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants
Nature Communications·2025Open Access
Mature dengue virus particles inactivated by a non-ionic detergent retain quaternary neutralizing epitopes and induce potent neutralizing antibodies
Frontiers in Immunology·2025Open Access
Structural elucidation of a unique binding mode by an intact alphavirus human IgG molecule to a quaternary epitope
Nature Communications·2025· 1 citedOpen Access
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines
npj Vaccines·2025· 3 citedOpen Access
Corrigendum to Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Journal of Clinical Investigation·2025Open Access
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine
Cell Reports·2025Open Access
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c Mice
2025Open Access
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine
Journal of Clinical Investigation·2025· 3 citedOpen Access
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
Nature Communications·2025· 3 citedOpen Access
page 1 of 42Next →

Frequent Co-authors

Michael Diamond(15), Pavlo Gilchuk(12), Seth J. Zost(10), Robert H. Carnahan(9), James Brett Case(7), Rita E. Chen(7), Rachel E. Sutton(7), Naveenchandra Suryadevara(7), John V. Williams(7), Benjamin J. Doranz(7), Nurgun Kose(7), Elad Binshtein(6), Rachel S. Nargi(6), Daved H. Fremont(6), Aravinda M. de Silva(6), Emma S. Winkler(5), Julie M. Fox(5), Gopal Sapparapu(5), Scott A. Smith(5), Andrew B. Ward(5)